Prolynx宣布任命Simon Harnest为首席财务官,并委任Amer Mirza博士担任首席科学官。此举旨在加速推进公司针对肥胖及代谢疾病的多项目研发组合。
Prolynx宣布任命Simon Harnest为首席财务官,并委任Amer Mirza博士担任首席科学官。此举旨在加速推进公司针对肥胖及代谢疾病的多项目研发组合。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.